<DOC>
	<DOC>NCT01314898</DOC>
	<brief_summary>24-hr urinary sodium/potassium ratio will be a sensitive biomarker of antimineralocorticoid activity. The dose-response relationship of the antimineralocorticoid activity of PF-03882845 can be established following single oral doses.</brief_summary>
	<brief_title>A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Male and/or female healthy volunteers, age 18 to 55 years. Females must be of nonchildbearing potential. Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight &gt;50 kg (110 lbs). Subjects who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, diet restrictions and other trial procedures. Subjects with a supine BP &gt;140 mm Hg systolic or &gt;90 mm Hg diastolic or &lt;100 mm Hg systolic or &lt;60 mm Hg diastolic based on the average of the triplicate Serum potassium &gt;=5.1 mmol/L or &lt;3.5 mmol/L at screening, confirmed by a single repeat if deemed necessary. Estimated GFR &lt;60 mL/min/1.73 m2 using the CockcroftGault formula measurement of the individual parameters following at least 5 minutes of rest at Screening.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Single dose</keyword>
	<keyword>cross-over</keyword>
	<keyword>active-control</keyword>
	<keyword>placebo control</keyword>
	<keyword>antimineralocorticoid activity</keyword>
</DOC>